Ethical considerations in research involving pregnant women

Women's Health Issues

Volumn 9, Issue 4, 1999, Pages 206-207

  Chervenak, F A ^a   McCullough, L B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; ETHICS; FEMALE; FETUS RISK; HEALTH CARE; HEALTH SERVICE; HUMAN; INFORMED CONSENT; NOTE; PREGNANCY;

AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS; FEDERAL GOVERNMENT; FEMALES; GENETICS AND REPRODUCTION; GOVERNMENT REGULATION; LEGAL APPROACH; OBSTETRICS AND GYNECOLOGY; PREGNANT WOMEN; PROFESSIONAL ORGANIZATIONS; RESEARCH SUBJECTS; RISKS AND BENEFITS; SELECTION OF SUBJECTS; UNITED STATES;

CLINICAL TRIALS; ELIGIBILITY DETERMINATION; ETHICS, MEDICAL; FEDERAL GOVERNMENT; FEMALE; GOVERNMENT REGULATION; HUMANS; INFORMED CONSENT; PATIENT SELECTION; PREGNANCY; PREGNANT WOMEN; RESEARCH; RESEARCH DESIGN; RESEARCH SUBJECTS; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 0032808220     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (14)

1. Robertson J. Ethical issues related to the inclusion of pregnant women in clinical trials (I). Mastroianni A.C., Faden R., Federman D. Women and health research ethical and legal issues of including women in clinical studies . Vol 2:1994;18-22 National Academy Press, Washington, DC.
2. Mastroianni A.C., Faden R., Federman D. Women and health research ethical and legal issues of including women in clinical studies . Vol 1:1994;188 National Academy Press, Washington, DC.
3. Connor E.M., Sperling R.S., Geber R., Kiselev P., Scott G., O'Sullivan M.J., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 331:1994;1173-1180.
4. Department of Health, Education, and Welfare. Protection of human subjects: fetuses, pregnant women, and in vitro fertilization. Federal Register 1975;40:33256, 33552.
5. Protection of Human Subjects, 45 C.F.R. Sect. 46(b) (1997).
6. Fetal Research, 42 U.S.C. Sect. 289g(b) (1996).
7. Beauchamp T.L., Childress J.F. Principles of biomedical ethics. 4th ed. 1994;441 Oxford University Press, New York.
8. Ethical dimensions of informed consent. ACOG Committee Opinion 108. 1992;ACOG, Washington, DC.
9. Mastroianni A.C., Faden R., Federman D. Women and health research ethical and legal issues of including women in clinical studies . Vol 1:1994;196 National Academy Press, Washington, DC.
10. Appelbaum P.S., Roth L.H., Lidz C.W., Benson P., Winslade W. False hopes and best data consent to research and the therapeutic misconception . Hastings Cent Rep. 17:1987;20-24.
11. Protection of Human Subjects, 45 C.F.R. Sect. 46.102(i) (1997).
12. Protection of Human Subjects, 45 C.F.R. Sect. 46.207(b) (1997); Sect. 46.208(b) (1997).
13. Protection of human subjects. Federal Register. 63:1998;27794-27804.
14. Beauchamp T. The intersection of research and practice. Goldworth A., Silverman W., Stevenson D.K., Rivers R., Young E.W. Ethics and perinatology. 1995;231-244 Oxford University Press, New York.